Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
Heart (British Cardiac Society)
|
January 25, 2020
Comorbidity and bystander cardiopulmonary resuscitation in out-of-hospital cardiac arrest
Geir Hirlekar, Martin Jonsson, Thomas Karlsson, et al.
Resuscitation
|
June 16, 2015
Out-of-hospital cardiac arrest in the elderly: A large-scale population-based study
Berglind Libungan, Jonny Lindqvist, Anneli Strömsöe, et al.
Vascular Health and Risk Management
|
September 23, 2010
Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
Elmir Omerovic, Truls Råmunddal, Per Albertsson, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 5, 2018
Breast cancer survival trends in different stages and age groups - a population-based study 1989-2013
Anna E Nordenskjöld, Helena Fohlin, Lars G Arnesson, et al.
European Journal of Pharmacology
|
August 24, 2010
A pharmacological analysis of the cholinergic regulation of urokinase-type plasminogen activator secretion in the human colon cancer cell line, HT-29
Ann Novotny, Karin Edsparr, Gunnar Nylund, et al.
Bioconjugate Chemistry
|
January 22, 2016
Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates
Emma Aneheim, Anna Gustafsson, Per Albertsson, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
April 1, 2022
Effects of Cardiac Rehabilitation on Physical Fitness, Physical Function, and Self-reported Outcomes in Patients ≥80 yr: A RANDOMIZED CONTROLLED TRIAL
Madeleine Brosved, Geir Hirlekar, Julia Philip Wigh, et al.
Cardiology
|
August 1, 2012
Stress-induced cardiomyopathy in Sweden: evidence for different ethnic predisposition and altered cardio-circulatory status
Tomas Schultz, Yangzhen Shao, Björn Redfors, et al.
Translational Oncology
|
September 28, 2020
Evaluation of therapeutic efficacy of <sup>211</sup>At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer
Stig Palm, Tom Bäck, Emma Aneheim, et al.
Clinical Cardiology
|
November 20, 2010
Long-term results following switch from abciximab to eptifibatide during percutaneous coronary intervention
Michael Koutouzis, Bo Lagerqvist, Jonas Oldgren, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
Heart (British Cardiac Society)
|
January 25, 2020
Comorbidity and bystander cardiopulmonary resuscitation in out-of-hospital cardiac arrest
Geir Hirlekar, Martin Jonsson, Thomas Karlsson, et al.
Resuscitation
|
June 16, 2015
Out-of-hospital cardiac arrest in the elderly: A large-scale population-based study
Berglind Libungan, Jonny Lindqvist, Anneli Strömsöe, et al.
Vascular Health and Risk Management
|
September 23, 2010
Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
Elmir Omerovic, Truls Råmunddal, Per Albertsson, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 5, 2018
Breast cancer survival trends in different stages and age groups - a population-based study 1989-2013
Anna E Nordenskjöld, Helena Fohlin, Lars G Arnesson, et al.
European Journal of Pharmacology
|
August 24, 2010
A pharmacological analysis of the cholinergic regulation of urokinase-type plasminogen activator secretion in the human colon cancer cell line, HT-29
Ann Novotny, Karin Edsparr, Gunnar Nylund, et al.
Bioconjugate Chemistry
|
January 22, 2016
Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates
Emma Aneheim, Anna Gustafsson, Per Albertsson, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
April 1, 2022
Effects of Cardiac Rehabilitation on Physical Fitness, Physical Function, and Self-reported Outcomes in Patients ≥80 yr: A RANDOMIZED CONTROLLED TRIAL
Madeleine Brosved, Geir Hirlekar, Julia Philip Wigh, et al.
Cardiology
|
August 1, 2012
Stress-induced cardiomyopathy in Sweden: evidence for different ethnic predisposition and altered cardio-circulatory status
Tomas Schultz, Yangzhen Shao, Björn Redfors, et al.
Translational Oncology
|
September 28, 2020
Evaluation of therapeutic efficacy of <sup>211</sup>At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer
Stig Palm, Tom Bäck, Emma Aneheim, et al.
Clinical Cardiology
|
November 20, 2010
Long-term results following switch from abciximab to eptifibatide during percutaneous coronary intervention
Michael Koutouzis, Bo Lagerqvist, Jonas Oldgren, et al.
Page
of 11